top of page
SCALE25_Web Banner_1920x855-01.png

Industry

Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience. 

Efficacy and Safety of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Caucasian Participants With Moderate to Severe Acne

Primary Author: Glynis Ablon MD

Screenshot 2025-05-09 at 11.26.28 AM.png
Industry_1.png

SYNCHRONOUS ULTRASOUND PARALLEL BEAM TECHNOLOGY FOR UPPER ARMS LAX SKIN APPEARANCE IMPROVEMENT

Primary Author: Dr. Ruthie Amir

Screenshot 2025-05-09 at 11.29.39 AM.png
Industry_2.png

SYNCHRONOUS ULTRASOUND PARALLEL BEAM TECHNOLOGY FOR Lift the Upper Lip (Philtrum) & improve Peri-Oral Rhytids

Primary Author: Dr. Ruthie Amir

Screenshot 2025-05-09 at 11.36.58 AM.png
Industry_3.png

Thiamidol: A Breakthrough Innovation in Treatment of Hyperpigmentation

Primary Author: Seemal Desai MD

Screenshot 2025-05-09 at 12.04.28 PM.png
Industry_4.png

Beyond Moisturization: Providing Cosmetic Anti-aging Benefits To Hand And Body

Primary Author: Lisa DiNatale M.S.

Screenshot 2025-05-09 at 12.08.21 PM.png
Industry_5.png

A Multi-Center, Open-Label Clinical Trial Evaluating a Plant Adaptogen Serum in Subjects with Mild-to-Moderate Persistent Centrofacial Erythema Associated with Rosacea

Primary Author: Zoe Draelos MD

Screenshot 2025-05-09 at 12.11.10 PM.png
Industry_6.png

A Single Center, Open-Label Trial Evaluated the Tolerability and Efficacy of an Advanced, Multimodal Skin Tone Correcting Serum in Subjects with Mild-to-Severe Dyschromia/Hyperpigmentation.

Primary Author: Zoe Draelos MD

Screenshot 2025-05-09 at 12.27.44 PM.png
Indusrty_7_.png

Long-Term Efficacy and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: A 24-Week Trial

Primary Author: Zoe Draelos MD

Screenshot 2025-05-09 at 12.37.05 PM.png
Indusrty_8.png

Effects of DaxibotulinumtoxinA or 150 kD botulinum toxin type A on extracellular matrix (ECM) protein production: An in vitro study

Primary Author: Conor Gallagher PhD

Screenshot 2025-05-09 at 12.42.51 PM.png
Industry_9.png

A systematic literature review and meta-analysis of the real-world effectiveness, quality of life outcomes, and safety of tildrakizumab for moderate-to-severe plaque psoriasis

Primary Author: Scott Gottlieb MD

Screenshot 2025-05-09 at 12.45.31 PM.png
Industry_10.png

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex

Primary Author: Julie Harper MD

Screenshot 2025-05-09 at 12.50.26 PM.png
Industry_11_.png

Efficacy and Safety of VYC-20L Maintenance Treatment for Temple Hollowing Correction: Results from a Multicenter Study

Primary Author: Derek Jones MD

Screenshot 2025-05-09 at 12.54.52 PM.png
Industry_12.png

From Lidocaine to Mepivacaine: The Next Chapter in HA Fillers

Primary Author: John H. Joseph M.D.

Screenshot 2025-05-09 at 12.57.47 PM.png
Industry_13.png

Plant protease enzymes improve wound inflammation by modifying macrophage function

Primary Author: Manishekhar Kumar PhD

Screenshot 2025-05-09 at 1.03.53 PM.png
Industry_14.png

Treatment of Ulcerated Infantile Hemangioma with Aquaphilus dolomiae ferment filtrate: A Case Report

Primary Author: Karan Lal

Screenshot 2025-05-09 at 1.07.22 PM.png
Industry_15.png

Nemolizumab treat-through analysis over 1 year in patients with prurigo nodularis bridging from randomized placebo-controlled trials to open-label extension study

Primary Author: Franz J. Legat MD 

Screenshot 2025-05-09 at 1.10.12 PM.png
Industry_16.png

Protective Effects of an Advanced Antioxidant Serum and an Encapsulated Vitamin C Serum from UV-Induced Erythema and Oxidative Stress in Human Skin.

Primary Author: Saeid Nik Doctor of Medicine, Doctor of Philosophy

Screenshot 2025-05-09 at 1.13.09 PM.png
Industry_17.png

Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23-Receptor, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, Randomized, Double-Blind, Placebo-Controlled ICONIC-LEAD Trial

Primary Author: Jeffrey Pawlikowski

Screenshot 2025-05-09 at 1.15.57 PM.png
Industry_18.png

Efficacy of Combination Monopolar Radiofrequency Tissue Tightening System and 1440-nm and 1927-nm Non-ablative Fractional Diode Laser System for the Treatment of Facial Skin Laxity, Skin Texture, and Pigmentation

Primary Author: John Peters MD

Screenshot 2025-05-09 at 1.20.11 PM.png
Industry_19.png

IMPACT OF CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE CREAM WITH PAD TECHNOLOGY (CAL/BPD PAD CREAM) ON SCALP-PGA SUCCESS, S-mPASI AND CLINICIAN SATISFACTION AMONG PATIENTS WITH MILD-TO-MODERATE SCALP PSORIASIS IN ROUTINE CLINICAL PRACTICES IN EUROPE. AN INTERIM ANALYSIS OF THE PRO-SCALP STUDY

Primary Author: Andreas Pinter MD

Screenshot 2025-05-09 at 2.18.21 PM.png
Industry_20_-_updated.png

PATIENT PREFERENCE OVER OTHER TOPICALS, PERCEPTION OF CREAM USABILITY, TREATMENT ADHERENCE AND SATISFACTION AMONG PATIENTS WITH MILD-TO-MODERATE SCALP PSORIASIS USING CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE CREAM WITH PAD TECHNOLOGY (CAL/BPD PAD CREAM) IN ROUTINE CLINICAL PRACTICES IN EUROPE. AN INTERIM ANALYSIS OF THE PRO-SCALP STUDY

Primary Author: Andreas Pinter MD

Screenshot 2025-05-09 at 2.02.57 PM.png
Industry_21.png

Clinical Evaluation of a Topical Eye Cream Containing a Fortifying Hyaluronic Acid and Peptide Blend on the Appearance of Dynamic Periorbital Lines

Primary Author: Kristine Schmalenberg PhD

Screenshot 2025-05-09 at 2.21.10 PM.png
Industry_22.png

SPECTREM: Guselkumab Demonstrates Consistent Significant Clearance Across the Full Range of Low Body Surface Area, Moderate Psoriasis With Special Sites Involvement

Primary Author: Kush Shah

Screenshot 2025-05-09 at 2.35.25 PM.png
Industry_23.png

VISIBLE COHORT A: Guselkumab Demonstrated Skin Clearance and Improved Health-Related Quality of Life Through Week 48 in Participants With Moderate-to-Severe Plaque Psoriasis Across All Skin Tones

Primary Author: Kush Shah

Screenshot 2025-05-09 at 2.37.44 PM.png
Industry_24.png

Synergistic Efficacy and Safety of Poly-L-Lactic Acid Biostimulator and Hyaluronic Acid Filler for Facial Fullness post Weight Loss due to Glucagon-like Peptide-1 Receptor Agonist Medication

Primary Author: Michael Somenek MD

Screenshot 2025-05-12 at 9.36.35 AM.png
Industry_25.png

Improved skin quality following treatment of forehead and glabellar lines with DaxibotulinumtoxinA

Primary Author: Brian Biesman, MD

Screenshot 2025-05-14 at 11.05.48 AM.png
Updated_Scale.png

Nemolizumab long-term safety and efficacy up to 56 weeks in ARCADIA open-label extension study in adolescents and adults with moderate-to-severe atopic dermatitis

Primary Author: Diamant Thaci MD

Screenshot 2025-05-12 at 9.45.11 AM.png
Industry_27.png

Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel, 12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287)

Primary Author: Patricia S Walker MD, PHDC

Screenshot 2025-05-12 at 9.47.58 AM.png
Industry_28.png

A Pilot Investigation of a Gummy-Based Hair Nutraceutical: Preliminary Efficacy Findings

Primary Author: Jandolyn Washington BA

Screenshot 2025-05-12 at 9.53.26 AM.png
Industry_29.png

A single-center, blinded, split-face controlled trial evaluated the safety and efficacy of a serum containing plant adaptogens compared to a moisturizer pre- and post-laser in subjects with mild-to-moderate photodamage.

Primary Author: Jacqueline Watchmaker, Doctor of Medicine

Screenshot 2025-05-12 at 9.57.00 AM.png
industry_30.png

Qualitative Development of the Natural Look Satisfaction Scale for the Treatment of Upper Facial Lines with Neurotoxin

Primary Author: Steve Yoelin MD

Screenshot 2025-05-12 at 10.02.45 AM.png
Industry_31.png

Enhancing Skin Rejuvenation: Optimizing Peri-Procedural Skincare for Superior Energy-Based Device Procedural Outcomes

Primary Author: Alisar Zahr PhD

Screenshot 2025-05-12 at 10.05.09 AM.png
Industry_32.png

HA Serum for Post Procedure Skin and Wound Repair: A Clinical Study to Assess the Speed and Quality of Post Laser Treatment Healing

Primary Author: Lyndsay Zotian PharmD/MBA

Screenshot 2025-05-12 at 10.08.01 AM.png
Industrt_33.png

Phone

123-456-7890

Follow Me

  • LinkedIn
  • Twitter

© 2035 By Nicol Rider.
Powered and secured by Wix

bottom of page